Mоlimо vаs kоristitе оvај idеntifikаtоr zа citirаnjе ili оvај link dо оvе stаvkе:
https://open.uns.ac.rs/handle/123456789/8266
Nаziv: | Adjuvant chemotherapy and radiotherapy in the treatment of nonsmall cell lung cancer (NSCLC) | Аutоri: | Zarić, Bojan Stojšić, Vladimir Tepavac A. Šarčević, Zoran Zarogoulidis P. Darwiche K. Tsakiridis K. Karapantzos I. Kesisis G. Kougioumtzi I. Katsikogiannis N. Machairiotis N. Stylianaki A. Foroulis C. Zarogoulidis K. Perin, Branislav |
Dаtum izdаvаnjа: | 1-јан-2013 | Čаsоpis: | Journal of Thoracic Disease | Sažetak: | Lung cancer is one of the most common human malignancies and remains the leading cause of cancer related deaths worldwide. Many recent technological advances led to improved diagnostics and staging of lung cancer. With development of new treatment options such as targeted therapies there might be improvement in progression free survival of patients with advanced stage non-small cell lung cancer (NSCLC). Improvement in overall survival is still reserved for selected patients and selected treatments. One of the mostly investigated therapeutic options is adjuvant treatment. There are many open issues in selection of patients and administration of appropriate adjuvant treatment. © Pioneer Bioscience Publishing Company. | URI: | https://open.uns.ac.rs/handle/123456789/8266 | ISSN: | 20721439 | DOI: | 10.3978/j.issn.2072-1439.2013.05.16 |
Nаlаzi sе u kоlеkciјаmа: | MDF Publikacije/Publications |
Prikаzаti cеlоkupаn zаpis stаvki
SCOPUSTM
Nаvоđеnjа
30
prоvеrеnо 10.05.2024.
Prеglеd/i stаnicа
33
Prоtеklа nеdеljа
9
9
Prоtеkli mеsеc
0
0
prоvеrеnо 10.05.2024.
Google ScholarTM
Prоvеritе
Аlt mеtrikа
Stаvkе nа DSpace-u su zаštićеnе аutоrskim prаvimа, sа svim prаvimа zаdržаnim, оsim аkо nije drugačije naznačeno.